Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 8 matching records
PRODUCTION OF VARIOUS STRENGTH OF IPDR CAPSULES FOR CLINICAL USE; POP: 05/08/2020 - 05/07/2021Department of Health and Human Services$223.8K obligationsEnds May 7, 2022
STABILITY TEST AT TIME POINT 48 MONTHS, QC AND QA REVIEW AND REPORTS BY IRISYS LLC:1259725 [POTS: 20-000431]Department of Health and Human Services$0 obligationsEnds Oct 30, 2019
DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF R-VK4-116, PERIOD OF PERFORMANCE 6/1/2021 - 5/31/2025.Department of Health and Human Services$702.8K obligationsEnds May 31, 2025
THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIALDepartment of Health and Human Services$735.7K obligationsEnds May 6, 2025
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72Department of Health and Human Services$748.5K obligationsEnds May 6, 2025
DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NES-100 NASAL SPRAYDepartment of Health and Human Services$2.0M obligationsEnds Apr 29, 2025
PLACEBO & ACTIVE IMIQUIMODDepartment of Veterans Affairs$0 obligationsEnds Mar 31, 2024
METARRESTIN CGMP MANUFACTURING AND STABILITY TESTING SERVICESDepartment of Health and Human Services$711.8K obligationsEnds May 22, 2028